In 2021, the total revenue of new oxygen increased by 30.7% year-on-year, and went deep into the supply chain to build a genuine ecosystem

On March 25, new oxygen technology released the latest data. In 2021, the company achieved a total revenue of 1.69 billion yuan, a year-on-year increase of 30.7%. The net profit attributable to listed companies under non US GAAP was 140 million yuan, a year-on-year increase of 42.4%. There were 6634 Payment institutions, a year-on-year increase of 19.1%. In 2021, the average monthly active users of new oxygen mobile terminals were 8.5 million, a year-on-year increase of 18.7%.

While the overall business is growing steadily, the new oxygen industry also continues to deepen the layout of the medical beauty industry chain, and through the acquisition of upstream brands, and in-depth cooperation, and using the Internet plus IOT technology to build Wuxi Online Offline Communication Information Technology Co.Ltd(300959) business model, and promote the healthy distribution of medical products and consumers. This will bring more possibilities for the long-term development of new oxygen.

Jinxing, chairman and CEO of new oxygen group, said: “In 2021, we are committed to strengthening trust with consumers, meeting the medical and aesthetic needs of consumers at different levels, and helping consumers make effective decisions. At the business level, we consolidated our existing competitive advantage, completed the acquisition of Wuhan Qizhi laser, and established a moat in the field of non-surgical consumption. In 2022, we will continue to improve our localized medical and aesthetic service capabilities and build a medical and aesthetic supply chain ecosystem, It covers the whole chain from medical beauty inquiry to consumption, and promotes the ecological layout of authentic products. “

In the past 2021, the total revenue and net profit of new oxygen both achieved significant growth, of which the total revenue was 1.69 billion yuan, a year-on-year increase of 30.7%. The net profit attributable to listed companies in non US GAAP was 140 million yuan, a year-on-year increase of 42.4%, far exceeding the growth rate of about 20% in the medical and American industry in 2021.

On the one hand, the growth of total revenue is due to the growth of the number of paid medical institutions. On the other hand, based on the company’s acquisition of Wuhan Qizhi laser, it not only improves the competitive barriers in the non-surgical field, but also further expands the source of revenue of the company. In 2021, there were 6634 new oxygen platform Payment institutions, with a year-on-year increase of 19.1%.

According to the data of medical beauty inspection, in the fourth quarter of 2021, the authentic cabinets were piloted in Beijing and Chengdu, covering 100 institutions in total. In the first quarter of 2022, the number of cities covered by authentic cabinets continued to increase. Cities such as Shanghai, Hangzhou, Wuhan and Chongqing have successively joined the camp of authentic cabinets. In 2022, it is expected to cover 30 key cities and more than 3000 institutions in China.

Yu Min, CFO of new oxygen technology, said: “we are very pleased to see strong revenue growth in 2021, which is very encouraging. Looking forward to the future, we will continue to improve operational efficiency and effectively control costs. While exploring new businesses, the company will continue to maintain healthy and sustainable revenue growth.”

- Advertisment -